transcodetherapeutics.com (RNAZ): Amount of Long-Term Liabilities

TransCode Therapeutics, Inc. (RNAZ) - corporate logo

Historical price action reflects the long-term debt of TransCode Therapeutics (RNAZ), which stands at 0.00. The startup's management aims to simplify drug delivery into the body to combat metastases. Operations rely on the ethical conduct of trials and strict adherence to environmental standards during the processing of chemical waste. Laboratory work is accompanied by basic energy control and the regulated disposal of hazardous biological materials.

RNAZ TransCode Therapeutics Inc.: Company Long-Term Debts in the range 07/04/2022 - 10/28/2026

Analytical breakdowns for TransCode Therapeutics, Inc. (RNAZ)

- price and consensus price forecast:
Stock Price TransCode Therapeutics Inc.|RNAZ - Consensus Target
- market capitalization data:
Market Value TransCode Therapeutics|RNAZ - Total Company Value
- book capitalization data:
Accounting Value of a Share TransCode Therapeutics|RNAZ - Book Capitalization|Market Capitalization to Book Value Ratio transcodetherapeutics.com|RNAZ - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity Ratio TransCode Therapeutics|RNAZ - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient TransCode Therapeutics Inc.|RNAZ - Company Aggregate Debts|Debt to Book Value TransCode Therapeutics|RNAZ - Company Long-Term Debt|Short-Term Debt TransCode Therapeutics
Fundamental company valuation:TransCode Therapeutics (RNAZ)
Manufactured products of TransCode Therapeutics

This indicator aggregates obligations with maturities exceeding one year, allowing for an assessment of the issuer's long-term debt load and financial stability. For TransCode Therapeutics (RNAZ), such funds are critical for ensuring stable supplies of RNA components through diversified logistics channels. By analyzing the company's long-term debt trajectory, an investor can identify borrowing trends prior to official reports. This minimizes the risk of capital losses. Monitoring this metric ensures balanced portfolio management.

Direct competitors

TEM - Company Long-Term Debts|Company Long-Term Liabilities Qiagen QGEN|IONS: Amount of Long-Term Liabilities|Company Long-Term Debt Repligen Corp. RGEN|Avidity Corp (RNA) - Company Long-Term Loans and Borrowings|CRSP (CRISPR Therapeutics AG) - Company Long-Term Debts|Company Long-Term Debts WGS|Company Long-Term Debt Ultragenyx RARE|Company Long-Term Indebtedness BEAM (Beam Therapeutics Inc)|Company Long-Term Debt SRPT|Long-Term Debt Volume Twist Bioscience Corp TWST|TXG: Company Long-Term Debts|NTLA: Company Long-Term Liabilities|Company Long-Term Debt STOK|BioLife Solutions Inc (BLFS) - Long-Term Debt|Company Long-Term Debts Wave Life Sciences Corp (WVE)|Company Long-Term Indebtedness Maze Therapeutics Corp|Sionna Therapeutics Inc - Company Long-Term Debts|Long-Term Debt primemedicine.com PRME|Company Long-Term Liabilities Taysha Gene Therapies, Inc.|QURE - Company Long-Term Loans and Borrowings|Company Long-Term Liabilities MeiraGTx PLC MGTX|RGNX - Amount of Long-Term Liabilities|Company Long-Term Debts Solid Biosciences Inc. SLDB|ocugen.com (OCGN) - Company Long-Term Loans and Borrowings|Company Long-Term Debts PACB (PacBio)|Long-Term Debt BNTC|Design Pharma (DSGN) - Company Long-Term Debt|Company Long-Term Loans and Borrowings Rocket Corp (RCKT)|Company Long-Term Debts FDMT (4D Molecular Therapeutics)|Lexeo Therapeutics Inc. - Company Long-Term Debts|Company Long-Term Debt Korro Bio, Inc|EDIT - Long-Term Liabilities|Company Long-Term Debts SLN|Long-Term Debt ProQR Therapeutics|CDXS (Codexis Inc) - Company Long-Term Liabilities|Company Long-Term Debts sangamo.com (SGMO)|Company Long-Term Liabilities Nautilus Biotechnology|Amount of Long-Term Liabilities Metagenomi Inc. (MGX)|Company Long-Term Debts DTIL|Long-Term Debt Volume Generation Bio Co GBIO|BOLD: Company Long-Term Debts|XCUR: Company Long-Term Liabilities|imunon.com - Company Long-Term Debt|PHIO (Phio Pharmaceuticals Corp.) - Long-Term Debt Volume|MBIO - Company Long-Term Debt|Company Long-Term Loans and Borrowings BNGO|Company Long-Term Debt Applied DNA Sciences APDN|Company Long-Term Indebtedness bluebirdbio.com (BLUE)|Company Long-Term Debts IPA (ImmunoPrecise Antibodies Ltd.)|OMGA - Company Long-Term Debts|Company Long-Term Liabilities Singular Genomics Systems Inc|RGLS - Long-Term Liabilities|Company Long-Term Debts Syros Pharmaceuticals|TBIO (telesisbio.com) - Company Long-Term Indebtedness|Company Long-Term Debt TRACON Pharmaceuticals, Inc. (TCON)|Company Long-Term Indebtedness Unity Biotechnology Inc.